Bharat Biotech starts re-labelling old stock after shelf life extension

After receiving the order from the Central Drugs Standard Control Organisation (CDSCO), the company started lifting unused stock from hospitals to re-label the shelf life from 9 months to 12 months

As India starts vaccinating its teenagers from Monday, Bharat Biotech, the maker of Covaxin, has picked up unused stock from private hospitals to re-label the shelf life. Covaxin is the only vaccine available for vaccination drive for teenagers now.

The company had in December said that the Central Drugs Standard Control Organisation (CDSCO) had approved a 12-month shelf life for Covaxin, which was nine months earlier.

“The company, after receiving the approval from the regulator on the extension of shelf life to 12 months, has already begun lifting the unused stock from private hospitals a few weeks ago at its own expense